Immunovant, Inc. (IMVT) vs Praxis Precision Medicines, Inc. (PRAX)
Immunovant, Inc. and Praxis Precision Medicines, Inc. are both Biotechnology companies. Praxis Precision Medicines, Inc. is the larger, with a market value of $7.9B against $7.1B — 1.1× the size. Across the 10 metrics below, Praxis Precision Medicines, Inc. leads on 7 and Immunovant, Inc. on 3.
Valuation
Profitability
| Metric | IMVT | PRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (80.10%) | (38.86%) | (57.72%) |
| Return on assets | (71.10%) | (36.80%) | (49.22%) |
| Return on invested capital | 0.00% | (40.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack